Effect of smoking status on response to thrombolytic therapy [1]

Journal of the American College of Cardiology

Volumn 28, Issue 1, 1996, Pages 283-

  Zahger, D ^a   Shah, P K ^a   Barbash, G I ^a   Reiner, J ^a   Ross, A M ^a   Califf, R M ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; LETTER; PREDICTION; PRIORITY JOURNAL; SMOKING; SURVIVAL;

EID: 0029792743     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/0735-1097(96)87143-9     Document Type: Letter

References (4)

1. G.I. Barbash J. Reiner H.D. White Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the “smoker's paradox” from the GUSTO-trial, with angiographic insights J Am Coll Cardiol 26 1995 1222 1229
2. G.I. Barbash H.D. White M. Modan Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial Circulation 87 1993 53 58
3. D. Zahger B. Cercek C.P. Cannon TIMI-4 Investigators How do smokers differ from non-smokers in their response to thrombolysis? Results from the TIMI 4 trial Am J Cardiol 75 1995 232 236
4. M.A. Gomez L.A. Karagounis A. Allen Effect of cigarette smoking on coronary patency after thrombolytic therapy for myocardial infarction Am J Cardiol 72 1993 373 378